Invention Grant
- Patent Title: Engineered primate cystine/cysteine degrading enzymes as antineogenic agents
-
Application No.: US16929438Application Date: 2020-07-15
-
Publication No.: US11426464B2Publication Date: 2022-08-30
- Inventor: George Georgiou , Everett Stone
- Applicant: Board of Regents, The University of Texas System
- Applicant Address: US TX Austin
- Assignee: Board of Regents, The University of Texas System
- Current Assignee: Board of Regents, The University of Texas System
- Current Assignee Address: US TX Austin
- Agency: Parker Highlander PLLC
- Main IPC: A61K38/51
- IPC: A61K38/51 ; C12N9/88 ; A61K45/06

Abstract:
Methods and compositions related to the engineering of a protein with L-cyst(e)ine degrading enzyme activity are described. For example, in certain aspects there may be disclosed a modified cystathionine-γ-lyase comprising one or more amino acid substitutions and capable of degrading L-cyst(e)ine. Furthermore, certain aspects of the invention provide compositions and methods for the treatment of cancer with L-cyst(e)ine using the disclosed proteins or nucleic acids.
Public/Granted literature
- US20200338197A1 ENGINEERED PRIMATE CYSTINE/CYSTEINE DEGRADING ENZYMES AS ANTINEOGENIC AGENTS Public/Granted day:2020-10-29
Information query
IPC分类: